Comparisons
SPACs vs traditional IPOs: the differences that actually matter
Both routes end with a listed company, but the risk, the cost and the disclosure land on different people. Here is where the two genuinely diverge.
Published Sep 4, 2026 · Updated Sep 4, 2026 · SPACListing research desk
A conventional IPO and a de-SPAC both end with a private company trading on a public exchange. Almost everything in between is different, and the differences decide who carries the risk and who pays for it.
The mechanics
| Traditional IPO | De-SPAC | |
|---|---|---|
| What happens | The company sells new shares to the public | The company merges into a listed shell that already holds cash |
| Price setting | A bookbuild, in the weeks before listing | Negotiated with the sponsor months earlier |
| Time to market | Six to twelve months, market permitting | Three to six months once an agreement is signed |
| Cash certainty | Known at pricing | Unknown until redemptions close |
| Who is diluted | Existing holders, by the new shares | Existing holders, plus the sponsor's promote and the warrants |
Price discovery is the real difference
In an IPO the price emerges from a bookbuild: institutions state what they will pay for how much, and the bank sets a clearing price. It is imperfect and it is often criticised for leaving money on the table, but it is a market process involving many buyers.
In a de-SPAC the price is negotiated between two parties, months before anyone else sees the numbers. Public shareholders do not set it. What they get instead is a veto in the form of redemption: they can decline the deal and take their cash back. That is a real protection, but it is a different thing from setting a price.
Certainty of proceeds, and why it broke
The classic pitch for a SPAC was certainty: the trust is already funded, so the target knows what it is getting. Redemptions destroyed that argument. When holders redeem at high rates, the trust empties, and a company that negotiated on the basis of a $300m trust can close with a fraction of it.
This is why PIPE financing became standard. Committed institutional money is the only part of a de-SPAC's funding that redemptions cannot touch, and a deal without one is a deal whose cash is entirely at the mercy of a vote.
Disclosure and liability
The most discussed difference was forward-looking projections. Merger communications historically enjoyed a safe harbour that IPO prospectuses do not, which is why de-SPAC decks carried five-year revenue forecasts that an IPO would never have printed. Regulators narrowed that gap deliberately, and the practical effect has been to make de-SPAC disclosure look far more like IPO disclosure.
Cost
An IPO's underwriting fee is visible: roughly 7% for a mid-size deal, paid by the company. A de-SPAC's cost is spread out and easier to underestimate. There is the underwriting fee on the SPAC's own IPO, the deferred portion paid at closing, the sponsor's promote of around 20%, the warrant overhang, and any discount conceded to the PIPE. Add them up and the de-SPAC is rarely the cheaper route, though it is frequently the faster one.
When each makes sense
- A conventional IPO suits a company with a clean track record, predictable numbers and time to run a process.
- A de-SPAC suits one that needs speed, or whose story depends on projections a bookbuild would not credit, or that wants a named sponsor alongside it.
- Neither suits a company that is not ready to be public. The route does not change the obligations that follow.
Questions people ask
Is a SPAC cheaper than an IPO?
Usually not, once the sponsor's promote and the warrant dilution are counted alongside the underwriting fees. It is often faster, and the price is agreed rather than discovered, but the total transfer of value from public shareholders tends to be larger.
Why would a company choose a SPAC over an IPO?
Speed, price certainty at signing, the ability to discuss forward projections in the deal materials, and a sponsor who brings capital and credibility. Companies with a story that a conventional bookbuild would discount have historically found the route attractive.
Which is safer for an investor?
Before a deal closes, a SPAC is the safer instrument by some distance: the cash sits in trust and the redemption right caps the downside. After closing, the comparison reverses, because the de-SPAC shareholder carries the sponsor's promote and the warrant overhang that an IPO buyer does not.
Written from public SEC filings and market practice. Not investment, legal or tax advice, and no substitute for the document in front of you.